Contact this trialFirst, we need to learn more about you.
Alkylating agents
Carboplatin Before Surgery for Prostate Cancer
Recruiting1 awardPhase 2
Longview, Washington
This trial tests if carboplatin before surgery can shrink prostate tumors in patients with high-risk cancer who have the BRCA1/2 gene mutation. Carboplatin kills/slows tumor growth similar to cisplatin but may be better tolerated.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service